Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension.
about
Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.The Efficacy of Fimasartan for Cardiovascular Events and Metabolic Syndrome (K-MetS Study): Rationale, Design and Participant Characteristics.Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cellsAzilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model.Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study.Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats.Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary interventionExpanded roles of the renin-angiotensin system.Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose.Effects of Xin-Ji-Er-Kang on Anticardiovascular Remodeling in L-NAME Induced Hypertensive Mice and Its Potential Mechanisms.
P2860
Q30278668-0771D259-EAAC-41B4-9DAE-98D0FD90ACB3Q35043165-0A797804-8BC8-47CD-8FE0-DD6D00CE70B3Q35121959-E9C731E2-50B3-4805-B064-4B7DDD949428Q35562699-047A7F39-1E6B-4329-ACF4-BCD44B0208EDQ36907473-5425A4C8-7766-4EF7-B794-48BFE9D6C214Q38953647-1E7CA440-8BEA-44DE-BEAB-1BA151E742EFQ42028373-621805F9-5E6F-48A7-965C-ACCDBB1F8546Q46976806-8B8E16B3-8446-44C6-AD72-FB92A8E7DE86Q51291016-BF52E72B-D56A-498C-8829-FD5AD57AF1A3Q55379467-B9327A5B-D042-471D-8673-B9043C38EC6D
P2860
Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Irbesartan, an angiotensin rec ...... s with high-risk hypertension.
@en
Irbesartan, an angiotensin rec ...... s with high-risk hypertension.
@nl
type
label
Irbesartan, an angiotensin rec ...... s with high-risk hypertension.
@en
Irbesartan, an angiotensin rec ...... s with high-risk hypertension.
@nl
prefLabel
Irbesartan, an angiotensin rec ...... s with high-risk hypertension.
@en
Irbesartan, an angiotensin rec ...... s with high-risk hypertension.
@nl
P2093
P2860
P356
P1476
Irbesartan, an angiotensin rec ...... s with high-risk hypertension.
@en
P2093
Isao Taguchi
Kazuhiko Takano
Koichi Node
Migaku Kikuchi
Mikie Ogawa
Shichiro Abe
Shigeru Toyoda
Takuo Arikawa
Teruo Inoue
P2860
P2888
P304
P356
10.1038/HR.2013.3
P577
2013-02-21T00:00:00Z
P6179
1033650524